Detailed Composition - Archaea

Archaea constitute a distinct domain of life from bacteria and eukaryotes. Although quantitatively they represent a smaller fraction of the human gut microbiome (generally <1-2%), they play a critical ecological role as metabolic regulators. Their primary function is methanogenesis: they consume the waste products of bacterial fermentation to produce methane, directly influencing intestinal transit speed and calorie extraction.

Often confused with bacteria due to their microscopic size, archaea possess a unique biochemistry and extremely resistant cell membranes that allow them to survive in hostile conditions. In the human gut, the absolutely dominant species is Methanobrevibacter smithii.

Their role in the ecosystem is that of hydrogen scavengers. When bacteria ferment fiber, they release gaseous hydrogen. If this hydrogen accumulates, fermentation stops (like an engine choked by its own smoke). Archaea capture this hydrogen and combine it with carbon dioxide to produce methane. This action, called syntrophy, allows bacteria to continue working efficiently, optimizing the complete digestion of food.

The presence and abundance of archaea is a clinical marker with direct implications in digestive physiology and metabolism:

• Intestinal Transit and Constipation: Methane is not an inert gas [cite: 117, 118]; it acts as a gaseous neurotransmitter that reduces intestinal peristaltic motility. Elevated levels of archaea (M. smithii) are strongly associated with chronic constipation and the methane-producing SIBO phenotype (IMO - Intestinal Methanogen Overgrowth).
• Body Weight and Energy Extraction: By removing excess hydrogen, archaea make bacterial fermentation thermodynamically more favorable. This leads to increased production of short-chain fatty acids that the body absorbs. Paradoxically, an excess of archaea has been linked to increased dietary energy harvesting and obesity risk.
• Cardiovascular Health: Recent research suggests a connection between certain oral and intestinal archaea and cholesterol metabolism, although their role as an atherosclerotic risk factor (via TMAO) is less prominent than in specific bacteria.

Detection of archaea using conventional methods (such as cultures or standard bacterial-targeted 16S PCR) often yields false negatives due to fundamental differences in their cell wall and genetic markers (archaeal 16S rRNA vs. bacterial). Shotgun metagenomics is the Gold Standard for this analysis, as it sequences total DNA without amplification biases.

Our bioinformatic analysis allows for the specific identification of Methanobrevibacter smithii and Methanobrevibacter stadtmanae, distinguishing them from transient environmental archaea.